Effect of SC extract on Rat Leydig cell testicular tumour LC-540 cells
The screening of
Saussurea costus (roots) for the % anti-proliferative activity on LC-540 cell line revealed highest activity at 200 µg/ml concentration after 72h of incubation (87.01±4.21). The anti-neoplastic activity of SC extract was found to be increased in a dose and time-dependent manner. The LC-540 cell line treated with DMSO did not exhibit marked changes in the morphology at three different time points. Vinblastine used as a standard drug to evaluate the anti-proliferative activity on LC-540 cell line showed drastic morphological changes. The 70% aqua ethanolic extract of
Saussurea costus (roots) elicited the prominent morphological changes including irregular nuclei, rounding of cells, fragmentation of cells and membrane blebbing on LC-540 cell line at 200 μg/ml concentration (Fig 1 and Fig 2).
Radiology
A qualitative radiological examination was done to assess the metastases of mammary tumours to lungs. The rats kept in group DX showed multifocal, 1-2 sized round foci on the lung parenchyma as compared with the groups treated with SC root extract. The rats in group SC3 revealed the presence of few foci on the lung surface, whereas animals in group SC1 were observed to show numerous whitish foci involving maximum surface of lung parenchyma corresponding to the lesions in the DMBA-only treated group (Fig 3).
Effect of SC extract on gross lesions in DMBA-induced pulmonary metastatic lesions
On gross examination of lungs number of metastatic foci (Fig 4A) and % area (Fig 4B) involved by metastatic foci were found to be significantly (P≤0.05) more in group II treated with DMBA only as compared with the group treated with the highest dose of the extract
i.
e. 500 mg/kg bw. The size of the metastatic foci in treatment groups was reduced in a dose-dependent manner as compared with group II. However, no level of significance was achieved (Fig 5A and Table 1).
Effect of SC extract on histopathological findings in DMBA-induced pulmonary metastatic lesions
A total of 7 rats in group I showed lung tumours, with 5 showing papillary carcinomas and 2 showing solid carcinomas on the lungs. Six rats in groups III and IV each had lung tumours, with 3 papillary carcinomas and 3 solid carcinomas. Five of the 8 rats in group V were found to have lung tumours with 2 having papillary carcinomas and 3 having solid carcinomas. In this study, the incidences of papillary carcinomas and solid carcinomas were 54.2% and 45.8%, respectively. The incidence of lung papillary carcinomas was decreased in the groups treated with SC extract in a dose-dependent manner as compared with group II treated with DMBA only. In papillary carcinomas involving epithelial cells in the bronchioles and alveoli displayed atypical proliferative changes, as well as marked pleomorphism, hyperchromasia and increased mucin secretions as a result of increased goblet cell activity. These proliferative changes were maximal in the group treated with DMBA only in comparison to the treatment groups provided with SC extract. Sheets of neoplastic cells with altered cellular morphology, hyperchromatic nuclei, prominent nucleoli and mitotic activity were more prominent in solid lung carcinomas (Fig 5B).
Effect of SC extract on MMP-9 expression in DMBA-induced pulmonary metastatic lesions
Immunohistochemical expression of MMP-9 was reduced in the groups treated with SC extract in a dose-dependent manner as compared with group II, however the significant (P≤0.05) decline was only seen in the group treated with the highest dose of the extract
i.
e. 500 mg/kg bw. MMP-9 expression was reduced in the groups III and IV as compared with only DMBA-treated group, but no level of significance (P≤0.05) was achieved (Fig 5C).
Breast cancer is the most common cancer diagnosed in women and the leading cause of death
(Ferlay et al., 2019). Metastatic breast cancer is the primary cause of breast cancer-related deaths, globally. The anti-neoplastic medications or therapies that are used to treat cancers do increase life expectancy but the quality of life is drastically decreased by their severe adverse side effects. For more than 2500 years, indigenous people have used
Saussurea costus in traditional and ethnopharmacological therapies for ailments such as gastroenteritis, ulcers, piles, throat infections, allergies, liver problems, typhoid, arthritis and impaired states of vata, pitta and kapla or trichosha
(Nadda et al., 2020). The active constituents present in
Saussurea costus are already documented to exhibit anti-cancerous potential against leukemia, breast cancer, prostate cancer, hepatocellular carcinomas, colon cancer, ovarian cancer
etc.
(Rathore et al., 2021).
In our study,
Saussurea costus root extract exhibited maximum anti-proliferative activity at 200 µg/ml concentration after 72 h of incubation. The anti-neoplastic activity revealed by SC extract was in a time and dose-dependent manner. In a previous study, conducted by
Okubo et al., (Okuboet_al2021) have documented the reduced HepG2 cells viability treated with methanolic extract of
S.
costus roots. In AGS (a human gastric adenocarcinoma cell-line),
S.
costus was reported to upregulate the expression of p53 and p21
(Ko et al., 2004). Dehydrocostus lactone, a bioactive molecule of
S.
costus root extract has also been shown to promote endoplasmic reticulum stress-mediated apoptosis and inhibit the PI3K/Akt/Bad pathway a dose-dependent manner in Hep-2 and TU212 cells, but little cytotoxicity was seen in human normal larynx epithelial HBE cells
(Zhang et al., 2020).According to
Ahmed et al., (2022), S.
costus oil had antineoplastic effects on MCF-7 (Breast carcinoma cells), HCT (colon carcinoma cells) and HepG-2 (liver carcinoma cells) cells.
S.
costus extract triggered apoptosis in man hepatocellular carcinoma (HepG2), colorectal adenocarcinoma (HCT116) and breast adenocarcinoma (MCF-7) cells by increasing the expression of Bax and by diminishing Bcl-2 and caspase-3 expressions
(Shati et al., 2020).
X-ray examination is one of the first line of investigation in the lung cancers and metastasis
(Bradley et al., 2019). Thoracic radiographs are comparatively cheap, accessible and have low radiation dose
(Hamilton, 2010). In the present study, the metastatic foci were more in number and size as compared with SC treatment groups in a dose-dependent manner. X-ray findings in our study were in concordance with the observations of Fouriez
Lablée
et_al(2017), which were also validated on post-mortem examination. One of the investigation concluded by
Currier et al., (2005), reported that DMBA can produce metastatic lesions in tissues other than mammary gland, including lungs, skin and lymphoid tissues. In the present experimental trial, gross examination of lungs in groups treated with DMBA alone exhibited substantially more metastatic foci in terms of both number and percent area affected as compared with groups treated with SC extract. Interestingly, the incidence of lung tumours was reduced in the groups treated with SC extract and a significant difference was observed in the group treated with the highest dose of the extract. Mice with DMBA induced tumor has shown high incidence of lung metastases in rat and mice models
(Arroyo-Acevedo et al., 2015; Plante et al., 2011). In our study, the incidence of lung tumours was reduced in the groups treated with SC extract and a significant difference was observed in the group treated with the highest dose of the extract
i.
e. 500 mg/kg and the group treated with DMBA only. On parallel lines, one of the studies has demonstrated the 100% incidence of pulmonary metastases in DMBA-induced mammary tumors in Hotlzman rats, which were significantly reduced in the group treated with ethanolic extract of
Piper aduncum (Arroyo-Acevedo
et al., 2015). In the present experimental study, lung papillary carcinomas occurrence was observed to be lower in the groups treated with SC extract, where the more pronounced solid carcinomas were present. Lung papillary carcinomas were more pronounced in the group II exclusively receiving DMBA treatment. Another study in DMBA-induced mammary tumors in BALB/c mice through oral route has documented 14.58% and 8.33% incidences of papillary lung tumor and mixed solid carcinomas, respectively (Duro De
Oliveira et al., 2015). As per one of the reports by
Wang et al., (2014) have shown the inhibition of pulmonary metastases in spontaneous and experimental study in Balb/c mice by
Panax notoginseng Saponins against 4T1 breast cancer cells.
Matrix metalloproteinases (MMPs) are the enzymes that breakdown collagen IV and V in extracellular matrix (ECM), which plays a crucial role in growth and metastases of tumours
(Stamenkovic, 2000). In the present study, a dosage-dependent reduction in the immunological expression of MMP-9 was observed in the groups treated with SC extract as compared to group II, although the significant fall was observed in group V given the highest dose of the extract. According to
Doyle and Miller (2008) and
Manshadi et al., (2018), increased immuno-expression of MMP-9 in breast cancer in humans is linked to advanced cancer stage, increased degree of histological undifferentiation, increased risk of metastases and death. Based on a study by
Aresu et al., (2011), MMP-9 expression is reported to be higher in females with more advanced and metastatic breast cancers and is in consonance with this study.